YXT.com Announces Receipt of Nasdaq Notice

Rhea-AI Summary

YXT.com (NASDAQ: YXT) received a Nasdaq Deficiency Letter dated Jan 26, 2026, for failing to meet the $1.00 minimum bid price for the last 30 consecutive business days.

The Deficiency Letter does not affect listing or trading today. The company has a 180-calendar-day compliance period ending July 27, 2026 to regain compliance or pursue a transfer application to the NASDAQ Capital Market.

Positive

• Deficiency Letter has no immediate trading suspension
• Company has a full 180-day compliance period until July 27, 2026
• Option to seek additional time via transfer application if eligible

Negative

• ADS closing bid was below the required $1.00 for 30 business days
• Risk of delisting if compliance is not restored by July 27, 2026
• May need a reverse stock split to cure the bid-price deficiency

Key Figures

Nasdaq minimum bid: US$1.00 per share Sub-US$1 period: 30 consecutive business days Compliance period: 180 calendar days +5 more

8 metrics

Nasdaq minimum bid US$1.00 per share Nasdaq Listing Rule 5450(a)(1) minimum bid price requirement

Sub-US$1 period 30 consecutive business days Closing bid below US$1.00 triggering Nasdaq deficiency notice

Compliance period 180 calendar days Time until July 27, 2026 to regain Nasdaq bid price compliance

Compliance deadline July 27, 2026 End of initial Nasdaq minimum bid price compliance period

Required compliant days 10 consecutive business days Minimum period with bid at or above US$1.00 to regain compliance

Current price US$0.72 Prior close before Nasdaq deficiency notice announcement

52-week high US$2.15 Pre-news 52-week high level for YXT

Shelf capacity US$100,000,000 Form F-3 shelf filed Dec 17, 2025 for potential offerings

Market Reality Check

Price: $0.7100 Vol: Volume 14,017 is below th...

low vol

$0.7100 Last Close

Volume Volume 14,017 is below the 20-day average of 29,154 (relative volume 0.48). low

Technical Price at 0.72 is trading below the 200-day MA of 0.86 and well under the 52-week high of 2.15.

Peers on Argus

Peers show mixed moves: PHUN +4.3%, NTWK +5.47%, HKIT -8.42%, MFI -2.27%, while ...

Peers show mixed moves: PHUN +4.3%, NTWK +5.47%, HKIT -8.42%, MFI -2.27%, while YXT was down 1.37%, indicating stock-specific pressure linked to its Nasdaq notice.

Historical Context

5 past events · Latest: Dec 17 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Dec 17	Shelf registration filing	Neutral	+6.2%	Filed Form F-3 shelf to allow up to US$100M of future securities offerings.
Oct 22	Nasdaq compliance regained	Positive	+0.0%	Nasdaq confirmed closing bids above US$1.00 for 11 days, closing deficiency matter.
Sep 18	Product launch event	Positive	+1.2%	Launched four new intelligent products and outlined AI-focused expansion strategy.
Aug 20	H1 2025 earnings	Negative	-7.0%	Reported revenue decline and swing to net loss with reduced subscription customers.
Aug 14	Earnings date notice	Neutral	+4.8%	Announced upcoming H1 2025 results release and conference call schedule.

Pattern Detected

Regulatory/listing updates and product news have generally seen modest moves, while weak financial results coincided with a sharper negative reaction.

Recent Company History

Over the last six months, YXT.com issued a Form F-3 shelf for up to US$100,000,000 in securities and previously reported regaining Nasdaq minimum bid price compliance on Oct 21, 2025. Product expansion included four new intelligent productivity offerings and ecosystem plans. Financially, H1 2025 results showed revenue of RMB152.9M and a swing to net loss, which drew a negative price reaction. Today’s new Nasdaq deficiency notice contrasts with the prior compliance win, highlighting renewed listing risk.

Regulatory & Risk Context

Active S-3 Shelf · US$100,000,000

Shelf Active

Active S-3 Shelf Registration 2025-12-17

US$100,000,000 registered capacity

An effective Form F-3 shelf filed on Dec 17, 2025 would allow YXT.com to offer and sell up to US$100,000,000 of various securities over time once effective, providing flexibility for future financings alongside potential resale offerings by selling shareholders.

Market Pulse Summary

This announcement highlights that YXT.com’s ADSs fell below Nasdaq’s US$1.00 minimum bid for 30 cons...

Analysis

This announcement highlights that YXT.com’s ADSs fell below Nasdaq’s US$1.00 minimum bid for 30 consecutive days, triggering a deficiency notice but not immediate delisting. The company has until July 27, 2026 to regain compliance, potentially via sustained price recovery or a reverse stock split. Recent history shows previous bid-price compliance and a filed US$100,000,000 Form F-3 shelf, but also operating losses. Investors may watch for concrete compliance steps and balance-sheet developments.

Key Terms

american depositary shares, nasdaq stock market, nasdaq capital market, reverse stock split, +2 more

6 terms

american depositary shares financial

"the closing bid price of the Company’s American depositary shares (the “ADSs”)"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

nasdaq stock market regulatory

"from the staff of the Listing Qualifications Department of the Nasdaq Stock Market LLC"

The Nasdaq Stock Market is a place where many companies' shares are bought and sold, functioning like a marketplace for investing in businesses. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping people grow their wealth or fund business growth. Known for hosting many technology and innovative companies, it is a key indicator of the health of those sectors.

nasdaq capital market regulatory

"submit, no later than July 27, 2026, a transfer application to listing on the NASDAQ Capital Market"

The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.

reverse stock split financial

"intention to cure the deficiency during the second compliance period by effecting a reverse stock split"

A reverse stock split is when a company reduces the number of its shares outstanding, making each share more valuable. For example, if you own 100 shares worth $1 each, a 1-for-10 reverse split would turn your 100 shares into 10 shares worth $10 each. Companies often do this to boost their stock price and appear more stable to investors.

minimum bid price regulatory

"was below the minimum bid price of US$1.00 per share requirement"

The minimum bid price is the lowest share price that a market, regulator, or specific offering will accept for a trade, listing, or auction—think of it as a reserve or floor that a stock must meet to qualify for certain actions. It matters to investors because falling below that floor can limit trading options, trigger compliance measures or delisting risks, and affect liquidity and the perceived value of a holding, much like a reserve price in an auction sets the baseline for a sale.

listing qualifications department regulatory

"written notification (the “Deficiency Letter”) from the staff of the Listing Qualifications Department"

A listing qualifications department is the part of a stock exchange that checks whether a company meets the exchange’s rules for being listed and staying listed. Think of it as a gatekeeper or building inspector: it reviews financial statements, disclosure practices and corporate governance, flags problems and can require fixes or remove a company’s shares. Investors care because its decisions affect whether a stock remains tradable and how much trust to place in a company’s reporting.

AI-generated analysis. Not financial advice.

SUZHOU, China, Jan. 28, 2026 (GLOBE NEWSWIRE) -- YXT.com Group Holding Limited (NASDAQ: YXT) (“YXT.com” or the “Company”), a provider of AI-enabled enterprise productivity solutions, today announced that it has received a written notification (the “Deficiency Letter”) from the staff of the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) dated January 26, 2026, indicating that for the last 30 consecutive business days, the closing bid price of the Company’s American depositary shares (the “ADSs”) was below the minimum bid price of US$1.00 per share requirement set forth in Nasdaq Listing Rule 5450(a)(1). The Deficiency Letter has no current effect on the listing or trading of the Company’s ADSs on Nasdaq.

Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until July 27, 2026 (the “Compliance Period”), to regain compliance with Nasdaq’s minimum bid price requirement. If at any time during the Compliance Period, the closing bid price of the Company’s ADSs is at least US$1.00 for a minimum of ten consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed.

In the event that the Company does not regain compliance by July 27, 2026, subject to the determination by the staff of Nasdaq, the Company may be eligible for additional time. To qualify, the Company must submit, no later than July 27, 2026, a transfer application to listing on the NASDAQ Capital Market. The Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split if necessary. As part of its review process, Nasdaq will make a determination of whether it believes the Company will be able to cure this deficiency. Should Nasdaq conclude that the Company will not be able to cure the deficiency, or should the Company determine not to submit a transfer application or make the required representation, Nasdaq will provide notice that its securities will be subject to delisting.

The Company intends to monitor the closing bid price of its ADSs between now and July 27, 2026 and is considering its options in order to regain compliance with the Nasdaq minimum bid price requirement. The Deficiency Letter does not affect the Company’s business operations, its U.S. Securities and Exchange Commission reporting requirements or contractual obligations.

About YXT.com

YXT.com (NASDAQ: YXT) is a technology company focusing on enterprise productivity solutions. With a mission to “Empower people and organization development through technology,” The Company strives to become the supreme provider in building and boosting enterprise productivity by combining over a decade of experience in tech-enabled talent learning and development and with AI-augmented task copilots and unleashing the power of knowledge and synergy. Since its inception, YXT.com has supported and received recognition from numerous Global and China Fortune 500 companies.

Safe Harbor Statement

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to”, or other similar expressions. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.

Contact

Investor Relations
YXT.com
E-mail: IR@radnova.com

Serena Huang
Octans Capital Group
E-mail: yxt.ir@octanscap.com
Tel: +86-10-6580-0653

FAQ

What did YXT (NASDAQ: YXT) receive on January 26, 2026?

YXT received a Nasdaq Deficiency Letter for failing to meet the $1.00 minimum bid price. According to the company, the letter notes a 30-business-day shortfall and triggers a 180-calendar-day compliance period ending July 27, 2026 to regain compliance.

How long is YXT’s Nasdaq compliance period and when does it end?

The compliance period is 180 calendar days and ends on July 27, 2026. According to the company, meeting a $1.00 closing bid for ten consecutive business days during that period will close the matter with Nasdaq.

What happens if YXT does not regain compliance by July 27, 2026?

If YXT does not regain compliance, Nasdaq may notify the company that its securities are subject to delisting. According to the company, eligibility for additional time requires submitting a transfer application to the NASDAQ Capital Market by July 27, 2026.

Can YXT avoid delisting without raising its ADS price above $1.00?

Potentially, YXT can seek a transfer application to the NASDAQ Capital Market as an alternative to price cure. According to the company, this requires meeting all initial listing standards except the bid-price rule and timely written notice of intent.

Will the Nasdaq Deficiency Letter affect YXT’s operations or SEC reporting?

No, the Deficiency Letter does not affect the company’s business operations or SEC reporting obligations. According to the company, the notice solely relates to the bid-price requirement and the Nasdaq review process.